BioGaia signs exclusive distribution agreement for its probiotic drops and tablets in Taiwan

(Thomson Reuters ONE) -


BioGaia signs exclusive distribution agreement for its probiotic drops and
tablets in Taiwan

Today BioGaia has signed an agreement with Unilab Group, for the exclusive
rights to sell BioGaia's probiotic drops and tablets in Taiwan. The products
will be sold under the BioGaia brand and launch is planned to 2012.

Unilab Group, based in the Philippines, is a leading pharmaceutical and
healthcare company in South East Asia. In Taiwan a distributor called Avipha
Biotechnology Co., Ltd, will sell the products, which will be marketed under
BioGaia's own brand. Both products contain BioGaia's patented and well-
researched probiotic strain Lactobacillus reuteri Protectis. Today the drops are
available in 51 countries worldwide and the tablets in 46.

BioGaia already has an agreement with Unilab Group for distribution of the
tablets in the Philippines, and with Unilab's subsidiary in China, SUCB, for the
drops.

- We are pleased with the agreement with Unilab/Avipha. As Taiwan has a
population of 23 million people and the standard of living is among the top 20
countries of the world, the potential for our probiotic products should be good,
says Peter Rothschild, President, BioGaia.



For additional information please contact
Peter Rothschild, President, telephone: +46 8 555 293 00



Latest press releases from BioGaia
2012-04-04 Notice to attend the annual general meeting of BioGaia AB (publ)
2012-03-21 The Board of BioGaia proposes that the AGE approve an extraordinary
dividend.
2012-02-22 Lactobacillus reuteri Protectis reduced diarrhoea in children

BioGaia has published this information in accordance with the Swedish Securities
Market Act. The information was issued for publication on 17 April 2012, 10:30
am CET.




Press release 17 April 2012 (pdf):

http://hugin.info/86913/R/1603073/506632.pdf



This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: BioGaia AB via Thomson Reuters ONE
[HUG#1603073]

Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
Datum: 17.04.2012 - 10:30 Uhr
Sprache: Deutsch
News-ID 135621
Anzahl Zeichen: 2629

contact information:
Town:

Stockholm

Kategorie:

Business News

Diese Pressemitteilung wurde bisher 150 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"BioGaia signs exclusive distribution agreement for its probiotic drops and tablets in Taiwan"
steht unter der journalistisch-redaktionellen Verantwortung von

BioGaia AB (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Changed date for BioGaia's Year-end report ...

BioGaia's Year-end report 2009 will be published on 22 February 2010 instead of on 18 February as was previous announced. Latest press releases from BioGaia: 2009-12-08 BioGaia nominates two Executive Vice Presidents 2009-10-22 Interim report 1 ...

BioGaia nominates two Executive Vice Presidents ...

The board of BioGaia has nominated Margareta Hagman and Urban Strindlöv as Executive Vice Presidents of the company as of April 1, 2010. Margareta is responsible for accounting, finance and administration whilst Urban is responsible for product deve ...

Interim report 1 January - 30 September 2009 ...

Interim report 1 January - 30 September 2009 - Net sales amounted to SEK 151.2 million (106.0), an increase of SEK 45.2 million (43%). - Operating profit was SEK 36.4 million (18.4), an increase of SEK 18 million. - Profit before tax was SEK 42.6 ...

Alle Meldungen von BioGaia AB